Algera IVS: Financial statements 2017
CVR: 38362593
Source: annual report 2017, Danish Business Authority
27/01/2017 – 31/12/2017
Algera IVS (CVR 38362593) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2017 report amounted to DKK 100. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 100
- Total Assets
- DKK 100
Official annual report
Keep an eye on Algera IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of November 3, 2017, Jens Christian Larsen is registered as director of Algera IVS.
As of November 3, 2017, Jørgen Fredebo Jørgensen has stepped down as director of Algera IVS.
On November 3, 2017, the company changed its name from SymbiCom IVS to Algera IVS.
As of January 27, 2017, Jørgen Fredebo Jørgensen is registered as director of Algera IVS.
Algera IVS was founded on January 25, 2017.
About Algera IVS
Algera IVS was a Danish company of the type Iværksætterselskab based in Vipperød, founded in 2017. The company has been dissolved on 28 September 2021. The company was registered under the industry Behandling og bortskaffelse af ikke-farligt affald. The company was previously named SymbiCom IVS. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2019 report amounted to DKK 100.